News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Daily News Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium L.A. McKeown October 02, 2020
News Conference News ESC 2020 Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients Shelley Wood September 04, 2020
News Daily News Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin Michael O'Riordan August 25, 2020
News Daily News Could Statins Curb Fatal or Severe COVID-19? Some Clues Michael O'Riordan August 14, 2020
News Daily News CV Prevention Meds Underused in Hispanic, Latinx PAD Patients L.A. McKeown August 12, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins L.A. McKeown August 04, 2020
News Conference News SCCT 2020 ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT Yael L. Maxwell July 20, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Conference News ACC 2020 Colchicine Cost-effective in Canada, and Even in the US: COLCOT Caitlin E. Cox March 28, 2020
News Daily News New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals Michael O'Riordan March 20, 2020
News Daily News Early CVD Readmissions and Mortality Patterns Differ in Canada and the US Yael L. Maxwell February 18, 2020
News Daily News ACC Releases Initial Cardiac Guidance on Novel Coronavirus Todd Neale February 13, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Daily News Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol Yael L. Maxwell January 28, 2020
News Daily News Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use L.A. McKeown January 21, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020